RNK Health review
Prices shown, disclosures absent
Publishes a pharmacy address and a month-to-month price, and not one word about compounded medications not being FDA-approved.
Our verdict
RNK Health gets two things right that many competitors here get wrong: it publishes a real month-to-month price rather than only a prepay rate, and it prints a pharmacy street address and phone number plus a separate medical-provider address. Then it omits the disclosure that matters most. Across its homepage and all five product pages there is no statement that compounded medications are not FDA-approved — no such statement exists anywhere on the site — while it sells five compounded products. That is the largest disclosure gap in this batch.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
At a glance
- Category
- Peptide telehealth
- Access
- NAD⁺ injection, nasal and liposomal all $169/mo month-to-month, $129/mo on a 6-month prepay — no compounded-medication disclaimer and no citations anywhere on the site
- Insurance
- Cash-pay, no insurance
- Visit
- Quiz intake / Async intake
- LegitScript
- Certified
- Updated
- August 2026
Popular alternative
Oak Longevity
Low-cost sermorelin within a broader longevity stack
Check Oak Longevity availability →What it is
A telehealth platform selling compounded NAD⁺ in three routes — injection, nasal and liposomal liquid, selectable on one page — sermorelin as an injection, enclomiphene, compounded semaglutide and tirzepatide, a B12-MIC lipotropic injection, and an 80-plus biomarker DNA panel. It advertises "Semaglutide, TRT, & Peptides" on its homepage, but there is no testosterone product on the site; the closest is enclomiphene, a selective oestrogen receptor modulator that stimulates your own production rather than supplying hormone. That mismatch is why it does not appear on our TRT board.
How it works
Asynchronous-first telehealth: a short free quiz, review and approval by a US clinician online, then delivery, with every product page leading to a quiz rather than a consultation booking. The site also claims a synchronous element — one-to-one calls with US doctors, physician consultation and unlimited access to a medical team bundled into the plan price — though the mechanics are not described. Self-pay with no insurance required, cancel or pause anytime, free shipping, no membership fee, and delivery claimed in 48 hours. Plan prices are visible before signup, which is better than several competitors here, though its own FAQ declines to publish pricing and says full details appear during checkout. Operational transparency is unusually good in one narrow respect and absent in every other: it publishes a pharmacy address and phone number in Springville, Utah and a separate medical-provider address in Des Moines, Iowa, but names neither the pharmacy business nor its 503A or 503B status, names no medical director or any individual clinician, and publishes no list of states served — the word "state" does not appear on its rendered pages at all.
Pricing transparency
Published, comparable, and internally contradictory. Both NAD⁺ and sermorelin run the same ladder: $169 a month month-to-month, $149 on a three-month plan billed roughly $447, and $129 on a six-month plan billed roughly $774. Because a genuine month-to-month tier exists and is displayed, the cards here carry $169 as the floor rather than the committed rate. The contradiction is on the same screen as the table. A block headed "One Price. Zero Hassle." reads "$129 — Everything. Included." with "no long-term contracts, cancel anytime" underneath — directly above the table that prices the monthly plan at $169 and reaches $129 only on a six-month prepayment. So $129 is presented as the monthly price in prose and as the committed price in the table, simultaneously. The savings claims do not hold together either: sermorelin's "save $100" on the monthly plan implies a $269 list price while its three- and six-month claims both imply $289, and no list price is ever shown. The three NAD⁺ route tabs carry identical prices with different savings baselines. Treat the ladder as real and the savings arithmetic as decorative.
Branded vs compounded
Compounded — and that is our statement, not theirs, because the site never makes it. Across the rendered homepage and all five product pages, the strings "FDA", "not approved" and "licensed" return zero hits. RNK sells compounded semaglutide, tirzepatide, NAD⁺, sermorelin and enclomiphene while saying only that its medications are "USA Compounded: lab-tested, high-purity". There is no statement that compounded drugs are not FDA-approved and have not been evaluated by the FDA for safety, quality or efficacy, and there is no citation of any kind anywhere on the site. Against that absence sit some of the strongest claims in this batch: NAD⁺ delivers "laser focus: clear the brain fog instantly" and "age backwards: repair your cells from the inside out"; tirzepatide makes food noise and hunger "disappear instantly"; results are "clinically-proven". The enclomiphene page is the sharpest case — it promises "the muscle, energy, and drive of TRT without the side effects on your fertility" and labels the product "Fertility Safe", an unqualified safety claim for a drug that is not FDA-approved for any indication. On the evidence: injected, intranasal and liposomal NAD⁺ have no controlled human outcome trials; the oral precursors NR and NMN raise blood NAD⁺, which is a biomarker rather than a benefit. Sermorelin acts on a real growth-hormone axis with thin long-term outcome data. Individual results vary.
Pros and watch-outs
What we like
- NAD⁺ in three routes — injection, nasal and liposomal — selectable on a single page at one price, which is rare and useful
- A genuine month-to-month plan at $169 is published, not just a committed rate
- Plan pricing is visible before the quiz rather than gated behind checkout
- Publishes a pharmacy street address and phone number, plus a separate medical-provider address
- Sells an 80-plus biomarker panel alongside the prescriptions
Watch-outs
- No compounded-medication disclaimer exists anywhere on the site, on five compounded products
- No citations of any kind appear on any page
- Advertises "Semaglutide, TRT, & Peptides" while selling no testosterone — only enclomiphene, a SERM
- Labels enclomiphene "Fertility Safe" and frames it as delivering the benefits of TRT, an unqualified safety claim on a drug not FDA-approved for any indication
- "$129 — Everything. Included." sits directly above a table pricing the monthly plan at $169
- Savings claims within a single table imply two different undisclosed list prices
- No states served published, and no medical director or clinician named
Best for
Buyers who already understand what compounded means, want to compare NAD⁺ delivery routes at one price, and want a month-to-month option.
Who should look elsewhere
First-time buyers of compounded medication, anyone seeking testosterone, and anyone who expects claims to carry citations.
The evidence behind what RNK Health prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- Sermorelin: a real GHRH drug, read against the anti-aging pitch
An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.
- NAD injections: how to get them near you or online, and what the evidence really says
Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
How RNK Health compares
A few alternatives worth a look, depending on what you’re optimizing for.
- Oak Longevity
Low-cost sermorelin within a broader longevity stack
See Oak Longevity → - HealthRX
Compounded sermorelin within a broad longevity and weight-care menu
See HealthRX → - Bodybuilding Health+
Pairing sermorelin with a strength-training and recovery focus
See Bodybuilding Health+ →
Pharmacology & mechanisms · Reviewed and last verified August 2026
How we assessed this. This review reflects Aminoscope’s own read of RNK Health’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Does RNK Health offer TRT?
- No, despite advertising it. Its homepage promises "Semaglutide, TRT, & Peptides that work", but there is no testosterone product on the site. The closest is enclomiphene, a selective oestrogen receptor modulator that stimulates your body's own testosterone production rather than supplying hormone directly. The two are not interchangeable, and enclomiphene is not FDA-approved for any indication.
- Is NAD⁺ $129 or $169 a month?
- $169 if you pay monthly. $129 requires a six-month prepayment of roughly $774. The page states both simultaneously — a block reading "$129 — Everything. Included." with "cancel anytime" underneath sits directly above the table pricing the monthly plan at $169. The table is the accurate one.
- Does RNK say its medications are compounded and not FDA-approved?
- It says they are compounded in the USA and lab-tested. It does not say anywhere that compounded medications are not FDA-approved or have not been evaluated by the FDA — that statement does not appear on its homepage or on any of its five product pages. Compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are, and you should know that before ordering.
- Which NAD⁺ route should I choose here?
- RNK prices injection, nasal and liposomal identically, so cost will not decide it. Nor, unfortunately, will evidence: none of the three has controlled human outcome trials behind it. The NAD⁺ forms with human trial data are the oral precursors NR and NMN, and what those trials show is a rise in blood NAD⁺ — a biomarker, not a demonstrated clinical benefit.